Contact Us
About
About Us
Leadership
Board of Directors
Vision, Mission, and Values
Pipeline
Pipeline Overview
Revumenib
Axatilimab
Entinostat
Publications & Meeting Presentations
Clinical Trials
Clinical Trials Overview
Revumenib Clinical Trials
AUGMENT-101 (monotherapy)
AUGMENT-102 (chemo combo)
Axatilimab Clinical Trials
Compassionate Use
Patients & Caregivers
Investors
Investors Overview
Press Releases
Events & Presentations
Corporate Governance
Governance Overview
Management
Board of Directors
Committee Composition
Contact the Board
Financial Information
Financial Overview
SEC Filings
Annual Reports and Proxies
Quarterly Results
Key Ratios
Stock Information
Stock Overview
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile
FAQs
Contact Us
Join Us
Contact Us
We’d love to hear from you.
Please fill out the form below and we’ll get back to you shortly.
Name*
*
Company*
*
Phone*
*
Email*
*
Interest/Title
*
Interested in AUGMENT-101 Clinical Trial (SNDX-5613)
Interested in AUGMENT-102 Clinical Trial (SNDX-5613)
Interested in AGAVE-201 Clinical Trial (Axatilimab)
Message
Δ
